HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic
| ISSN: |
1432-1440
|
|---|---|
| Keywords: |
Intravenous drug abusers ; Acquired immunodeficiency syndrome ; Immunocompetence ; Longitudinal study ; LAV/HTLV-III
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Medicine
|
| Notes: |
Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue.
|
| Type of Medium: |
Electronic Resource
|
| URL: |
| _version_ | 1798295719064371201 |
|---|---|
| autor | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| autorsonst | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| book_url | http://dx.doi.org/10.1007/BF01785522 |
| datenlieferant | nat_lic_papers |
| hauptsatz | hsatz_simple |
| identnr | NLM199373981 |
| issn | 1432-1440 |
| journal_name | Journal of molecular medicine |
| materialart | 1 |
| notes | Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue. |
| package_name | Springer |
| publikationsjahr_anzeige | 1987 |
| publikationsjahr_facette | 1987 |
| publikationsjahr_intervall | 8014:1985-1989 |
| publikationsjahr_sort | 1987 |
| publisher | Springer |
| reference | 65 (1987), S. 22-26 |
| schlagwort | Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III |
| search_space | articles |
| shingle_author_1 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| shingle_author_2 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| shingle_author_3 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| shingle_author_4 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. |
| shingle_catch_all_1 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue. 1432-1440 14321440 Springer |
| shingle_catch_all_2 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue. 1432-1440 14321440 Springer |
| shingle_catch_all_3 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue. 1432-1440 14321440 Springer |
| shingle_catch_all_4 | Paschelke, G. Altvater-Kremer, G. Meyer, W. D. Kremer, H. HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Intravenous drug abusers Acquired immunodeficiency syndrome Immunocompetence Longitudinal study LAV/HTLV-III Summary To date, long-term intravenous drug users studied at regional European centers of illicit drug use have had a high number of LAV/HTLV-III infections. Among 200 patients remanded by court or referred from prison to a special clinic in northern Germany for young delinquent drug abusers, 26 (17%) of 157 IV drug abusers were HTLV-III seropositive. With 40% seropositive, female patients showed a significantly higher prevalence of HTLV-III infection than males. The results of longitudinal serological, immunological, and clinical observations over periods of 12 months and 2–3 years indicate that under conditions of continuous medical surveillance, sound preventive counseling, and steady therapeutic care during long-term coeducative residential treatment of drug abusers, neither detectable HTLV-III transmission nor definite progression of HTLV-III induced impairment of immune regulatory functions must ensue. 1432-1440 14321440 Springer |
| shingle_title_1 | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| shingle_title_2 | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| shingle_title_3 | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| shingle_title_4 | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| sigel_instance_filter | dkfz geomar wilbert ipn albert fhp |
| source_archive | Springer Online Journal Archives 1860-2000 |
| timestamp | 2024-05-06T09:40:39.788Z |
| titel | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| titel_suche | HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a north-German drug clinic |
| topic | WW-YZ |
| uid | nat_lic_papers_NLM199373981 |